Reliability of data collection for the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multi-center outcomes database: A methodological approach

被引：0
|
作者：
Kho, M. E.
Lepisto, E. M.
Niland, J. C.
terVeer, A.
LaCasce, A. S.
Friedberg, J. W.
Weeks, J. C.
机构：
[1] Dana Farber Canc Inst, Hamilton, ON, Canada
[2] Natl Comprehens Canc Network, Jenkintown, PA USA
[3] City Hope Comprehens Canc Ctr, Duarte, CA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6525
引用
收藏
页数：1
相关论文
共 39 条
  • [1] Reliability of Staging, Prognosis, and Comorbidity Data Collection in the National Comprehensive Cancer Network (NCCN) Non-Hodgkin Lymphoma (NHL) Multicenter Outcomes Database
    Kho, Michelle E.
    Lepisto, Eva M.
    Niland, Joyce C.
    Friedberg, Jonathan W.
    LaCasce, Ann S.
    Weeks, Jane C.
    CANCER, 2008, 113 (11) : 3209 - 3212
  • [2] Natural History of Transformed Non-Hodgkin Lymphoma in the Rituximab Era: Analysis of the National Comprehensive Cancer Network (NCCN) NHL Outcomes Database.
    Ban-Hoefen, Makiko
    Vanderplas, Ann
    Kelly, Jennifer L.
    Crosby-Thompson, Allison
    Abel, Gregory A.
    Czuczman, Myron S.
    Gordon, Leo I.
    Kaminski, Mark S.
    Millenson, Michael
    Nademanee, Auayporn
    Rodriguez, Maria A.
    Zelenetz, Andrew D.
    Niland, Joyce
    LaCasce, Ann
    Friedberg, Jonathan W.
    BLOOD, 2012, 120 (21)
  • [3] Potential impact of pathologic review on therapy in non-Hodgkin's lymphoma (NHL): Analysis from the national comprehensive cancer network (NCCN) NHL outcomes project
    LaCasce, A
    Niland, J
    Kho, ME
    TerVeer, A
    Friedberg, JW
    Rodriguez, MA
    Czuczman, MS
    Millenson, M
    Zelenetz, AD
    Nademanee, AP
    Weeks, JC
    BLOOD, 2005, 106 (11) : 789A - 789A
  • [4] Outcomes with Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Relapsed/Refractory Follicular Lymphoma (FL) in the Post-Rituximab Era: A Comparative Analysis From the National Comprehensive Cancer Network (NCCN) Non-Hodgkin's Lymphoma (NHL) Outcomes Database Project
    Evens, Andrew M.
    Vanderplas, Ann
    LaCasce, Ann
    Crosby, Allison
    Nademanee, Auayporn
    Kaminski, Mark S.
    Abel, Gregory A.
    Millenson, Michael
    Czuczman, Myron S.
    Rodriguez, Maria A.
    Niland, Joyce
    Zelenetz, Andrew D.
    Gordon, Leo I.
    Friedberg, Jonathan
    BLOOD, 2011, 118 (21) : 1756 - 1757
  • [5] Newly diagnosed follicular (FL), mantle cell (MCL), and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in 5 United States comprehensive cancer centers: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project.
    Friedberg, JW
    Kho, ME
    Lepisto, EM
    Rodriguez, MA
    TerVeer, A
    LaCasce, AS
    Nademanee, AP
    Millenson, M
    Czuczman, M
    Niland, J
    Zelenetz, AD
    Weeks, JC
    BLOOD, 2004, 104 (11) : 391A - 391A
  • [6] Utilization of rituximab therapy in patients (pts) with newly diagnosed follicular (FL) and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in the United States: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project.
    Friedberg, JW
    Lepisto, E
    Rodriguez, MA
    Ottensen, R
    LaCasce, AS
    Nademanee, AP
    Millenson, M
    Czuczman, M
    Niland, J
    Zelenetz, AD
    Weeks, J
    BLOOD, 2003, 102 (11) : 494A - 494A
  • [7] Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network
    LaCasce, Ann S.
    Kho, Michelle E.
    Friedberg, Jonathan W.
    Niland, Joyce C.
    Abel, Gregory A.
    Rodriguez, Maria Alma
    Czuczman, Myron S.
    Millenson, Michael M.
    Zelenetz, Andrew D.
    Weeks, Jane C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (31) : 5107 - 5112
  • [8] Allogeneic hematopoietic stem cell transplantation (allo-HSCTs) for non-Hodgkin lymphoma (NHL): outcomes at the National Cancer Center Hospital (NCCH) of Japan
    Watanabe, M.
    Kim, S. -W.
    Aoki, J.
    Tanaka, T.
    Ito, A.
    Inamoto, Y.
    Fukuda, T.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 65 - 66
  • [9] Results of a multi-center, phase II study of Elsamitrucin (SPI-28090) in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL).
    Foon, K
    Allen, S
    Sen, K
    Mohrbacher, A
    Sanani, S
    Lenaz, L
    Rosales, R
    BLOOD, 2005, 106 (11) : 265B - 266B
  • [10] Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey
    Uysal, Ayse
    Soyer, Nur Akad
    Ozdogu, Hakan
    Goker, Hakan
    Cinar, Olgu Erkin
    Deveci, Burak
    Yilmaz, Asu Fergun
    Atagunduz, Isik Kaygusuz
    Tekgunduz, Ali Irfan Emre
    Izmir, Sebnem Guner
    Vural, Filiz
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 43 - 52
1234